{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:40:40Z","timestamp":1793691640421,"version":"4.5.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"the BMBF"},{"DOI":"10.13039\/501100001659","name":"the Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jhep.2010.01.014","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T09:27:31Z","timestamp":1266226051000},"page":"514-522","source":"Crossref","is-referenced-by-count":333,"title":["Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective"],"prefix":"10.1016","volume":"52","author":[{"given":"Jerzy","family":"Jaroszewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Calle","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Wursthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Deterding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Schlue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Raupach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Flisiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-Thomas","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.01.014_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \u201cNew\u201d antigen in leukemia sera","volume":"191","author":"Blumberg","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2010.01.014_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jcp.21416","article-title":"Hepatitis B virus\u2013cell interactions and pathogenesis","volume":"216","author":"Nguyen","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jhep.2010.01.014_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2008.02896.x","article-title":"Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus","volume":"126","author":"Op den Brouw","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2010.01.014_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.014_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2008.01013.x","article-title":"The German guideline for the management of hepatitis B virus infection: short version","volume":"15","author":"Cornberg","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2010.01.014_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/305158a0","article-title":"Enhanced luminescence procedure for sensitive determination of peroxidase-labelled conjugates in immunoassay","volume":"305","author":"Whitehead","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2010.01.014_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0166-3542(94)90022-1","article-title":"Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy","volume":"23","author":"Janssen","year":"1994","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2010.01.014_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay","volume":"115","author":"Deguchi","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jhep.2010.01.014_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcv.2006.06.011","article-title":"Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B","volume":"37","author":"Rodella","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2010.01.014_bib10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/jmv.21179","article-title":"What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?","volume":"80","author":"Galli","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2010.01.014_bib11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/hep.22760","article-title":"Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B","volume":"49","author":"Brunetto","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.22744","article-title":"Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients","volume":"49","author":"Moucari","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib13","first-page":"714A","article-title":"On-treatment HBsAg decline during peginterferon alfa-2a (40kD)\u00b1lamivudine in patients with HBeAg-positive CHB as a potential predictor of durable off-treatment response","volume":"48","author":"Lau","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/jmv.21519","article-title":"Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B","volume":"81","author":"Borgniet","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2010.01.014_bib15","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0168-8278(09)60019-2","article-title":"Kinetics of HBsAg decline in HBeAg+ chronic hepatitis B patients with 3 years of telbivudine treatment during the Globe study","volume":"50","author":"Wursthorn","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.014_bib16","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.01.014_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.21282","article-title":"Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B","volume":"44","author":"Wursthorn","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/j.gastro.2007.06.057","article-title":"Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients","volume":"133","author":"Volz","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.01.014_bib19","first-page":"371A","article-title":"HBsAg serum levels correlate with total liver HBV DNA but not with cccDNA","volume":"48","author":"Manesis","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib20","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/S0168-8278(09)60569-9","article-title":"Relationship between HBV cccDNA and HBsAg levels is associated with HBeAg statuses of chronic hepatitis B patients","volume":"50","author":"Lu","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.014_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/135965350801300402","article-title":"A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels","volume":"13","author":"Wiegand","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2010.01.014_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.014_bib23","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1002\/hep.20956","article-title":"Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005","volume":"43","author":"Yim","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2007.07.038","article-title":"The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus\u2013host relationship based on molecular virology and immunopathogenesis considerations?","volume":"133","author":"Thompson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.01.014_bib25","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.21188","article-title":"Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam","volume":"43","author":"Toan","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/jmv.21294","article-title":"Prevalence of HBV genotypes in Central and Eastern Europe","volume":"80","author":"Deterding","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2010.01.014_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.01.014_bib28","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"Lau","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.01.014_bib29","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa040431","article-title":"Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B","volume":"351","author":"Marcellin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.01.014_bib30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cgh.2007.09.005","article-title":"Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response","volume":"5","author":"Chan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.01.014_bib31","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1073\/pnas.0403925101","article-title":"Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration","volume":"101","author":"Bill","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2010.01.014_bib32","doi-asserted-by":"crossref","unstructured":"Chemin I, Zoulim F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett 2009 Jan 13 [Epub ahead of print].","DOI":"10.1016\/j.canlet.2008.12.003"},{"key":"10.1016\/j.jhep.2010.01.014_bib33","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.77.7.4033-4042.2003","article-title":"Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB","volume":"77","author":"Biermer","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2010.01.014_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.20353","article-title":"Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21345","article-title":"Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens","volume":"44","author":"Sugiyama","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(00)80279-2","article-title":"Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity","volume":"33","author":"Grandjacques","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.014_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.21723","article-title":"Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis","volume":"46","author":"Buster","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.014_bib38","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1053\/j.gastro.2009.01.011","article-title":"Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients","volume":"136","author":"Kumar","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.01.014_bib39","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1317","article-title":"Platelets mediate cytotoxic T lymphocyte-induced liver damage","volume":"11","author":"Iannacone","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2010.01.014_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2009.05.005","article-title":"On the role of platelets in the pathogenesis of viral hepatitis","volume":"51","author":"Iannacone","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.014_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.2007.128496","article-title":"Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years","volume":"57","author":"Fattovich","year":"2008","journal-title":"Gut"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781000022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781000022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T07:22:26Z","timestamp":1685431346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882781000022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S016882781000022X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.01.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}